It suppresses miR-96/MEG2/pSTAT3 signaling in cervical cancer cells [24] and inhibits cancer angiogenesis by enhancing mitochondrial dysfunction and oxidative stress through sodium-channel-independent mitochondria [25]. The gene discussed is PTPN9; the disease is cervical carcinoma.